Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,388.80
-1.40 (-0.10%)
Sep 11, 2026, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 170.22 billion as of September 11, 2026. Its market cap has increased by 45.34% in one year.
Market Cap
170.22B
Enterprise Value
162.96B
Revenue
25.90B
Ranking
n/a
PE Ratio
28.28
Stock Price
1,388.80
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 170.22B, an increase of 85.60%. That is a compound annual growth rate of 12.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 170.22B | 51.37% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 372.30B |
| Wockhardt | 360.83B |
| Piramal Pharma | 282.46B |
| Eris Lifesciences | 187.98B |
| Cohance Lifesciences | 170.36B |
| Alembic Pharmaceuticals | 160.47B |
| NATCO Pharma | 146.63B |
| Sudeep Pharma | 137.06B |